.jpg)
Associate Professor
Barbara Davis Center for Diabetes
Aurora, Colorado, United States
Dr. Shah is an Associate Professor at the Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus. His research is focused on improving glycemic control and reducing complications, with special interest in fracture prevention, in people with type 1 diabetes.
Dr. Shah has been the PI for many clinical trials of diabetes technologies and therapeutics. He has been a part of landmark research such as REPLACE-BG, WISDM, Artificial pancreas Cambridge (ApCam), Omnipod 5 HCL, and Dexcom G6 pivotal that led to FDA approval of newer devices and changed the type 1 diabetes management. Moreover, his interest in understanding the effect of diabetes on bone fragility had led to two NIH-funded studies investigating effect of long-standing T1D on bone tissue material properties (AR075099) and factors affecting bone density (vBMD), bone mechanical properties in adults with type 1 diabetes (DK122554).
Dr. Shah has served in many leadership positions such as steering committee member for T1D Exchange Clinic Registry (2016-2017). He is currently serving as Chair-Elect, for the Diabetes Technology Interest Group and Scientific Session Planning Committee at the American Diabetes Association and a writing committee member for the American College of Endocrinology Self-Assessment Program (2020-2022). He is the recipient of prestigious AACE Rising Star in Endocrinology Award (2021) and ADA Diabetes Technology Interest Group Award (2022).
He serves as the Editor-in-Chief for Clinical Diabetology, Senior Editor for the Endocrine Connections and Section Editor for Current Opinion in Endocrinology, Diabetes and Obesity. He is well published with over 100 research publications including original article, invited reviews, editorials, and book chapters.
Friday, May 5, 2023
1:00 PM – 1:45 PM
Saturday, May 6, 2023
9:00 AM – 12:30 PM